Change in N-terminal pro-B-type natriuretic peptide at 1 year predicts mortality in wild-type transthyretin amyloid cardiomyopathy

OBJECTIVES: Wild-type transthyretin amyloid cardiomyopathy (wtATTR-CM) is a progressive and fatal condition. Although prognosis can be determined at the time of diagnosis according to National Amyloidosis Centre (NAC) transthyretin amyloidosis (ATTR) stage, the clinical course varies substantially b...

Descripción completa

Detalles Bibliográficos
Autores principales: Law, Steven, Petrie, Aviva, Chacko, Liza, Cohen, Oliver C, Ravichandran, Sriram, Gilbertson, Janet A, Rowczenio, Dorota, Wechalekar, Ashutosh D, Martinez-Naharro, Ana, Lachmann, Helen J, Whelan, Carol J, Hutt, David F, Hawkins, Philip N, Fontana, Marianna, Gillmore, Julian D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Heart Failure and Cardiomyopathies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899483/
https://www.ncbi.nlm.nih.gov/pubmed/33990410
http://dx.doi.org/10.1136/heartjnl-2021-319063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899483/
https://www.ncbi.nlm.nih.gov/pubmed/33990410
http://dx.doi.org/10.1136/heartjnl-2021-319063

Ejemplares similares